Immunome Portfolio News

Immunome Appoints Jean-Jacques Bienaimé to Board of Directors

By WebmasterNovember 8, 2023December 12th, 2024No Comments

Immunome Appoints Jean-Jacques Bienaimé to Board of Directors

– Accomplished biotechnology and pharmaceutical executive with over three decades of experience to join Immunome’s Board of Directors

Previous PostImmunome Reports Third Quarter 2023 Financial Results
Next PostENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in Platinum Refractory/ Resistant Ovarian Cancer at SITC 2023